Avalo Therapeutics CEO Garry Neil's 2022 pay rises 8% to $1.3M
Avalo Therapeutics reports 2022 executive compensation
By ExecPay News
Published: October 19, 2023
Avalo Therapeutics reported fiscal year 2022 executive compensation information on October 19, 2023.
In 2022, four executives at Avalo Therapeutics received on average a compensation package of $1M, a 33% decrease compared to previous year.
Average pay of disclosed executives at Avalo Therapeutics
Garry Neil, Chief Executive Officer, received $1.3M in total, which increased by 8% compared to 2021. 55% of Neil's compensation, or $731K, was in option awards. Neil also received $133K in non-equity incentive plan and $469K in salary.
Stephen Smolinski, Former Chief Commercial Officer, received a compensation package of $991K. 49% of the compensation package, or $490K, was in option awards.
Michael Cola, Chief Executive Officer, earned $945K in 2022, a 65% decrease compared to previous year.
Christopher Sullivan, Chief Financial Officer, received $769K in 2022, which increases by 22% compared to 2021.
Related executives
You may also like
Source: SEC filing on October 19, 2023.